Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetesJūlı́us Guðmundsson, Theresa Graif, Guðmar Þorleifsson et al.|Nature Genetics|2007Cited by 725
Granulocyte Colony-Stimulating Factor in the Treatment of High-Risk Febrile Neutropenia: a Multicenter Randomized TrialRocio García‐Carbonero, L. Paz-Ares, José Mayordomo et al.|JNCI Journal of the National Cancer Institute|2001Cited by 179